retatrutide clinical trials phase Eli Lilly infiltrates anti-obesity market as III trial for begins Eli Lilly's triple agonist, retatrutide,

Now, next generation GLP 1 & GIP weight loss support medications are also available

Graeme Bell and colleagues identified the sequences of hamster and human proglucagon [24, 25], with other labs rapidly elucidating the bovine [26] and rat [27] proglucagon sequences

For metabolic health and appetite management, the GLP-1 Probiotic or Pro version makes the most sense

Across the GLP-1 class (semaglutide, tirzepatide), most patients regain a substantial portion of lost weight within 12 months of stopping the drug

The tirzepatide and alcohol guide and semaglutide and alcohol guidance provide specific recommendations that apply to retatrutide as well

doi: 10.12688/f1000research.12120.1